Back to Search Start Over

Retromer dysfunction in amyotrophic lateral sclerosis.

Authors :
Pérez-Torres EJ
Utkina-Sosunova I
Mishra V
Barbuti P
De Planell-Saguer M
Dermentzaki G
Geiger H
Basile AO
Robine N
Fagegaltier D
Politi KA
Rinchetti P
Jackson-Lewis V
Harms M
Phatnani H
Lotti F
Przedborski S
Source :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jun 28; Vol. 119 (26), pp. e2118755119. Date of Electronic Publication: 2022 Jun 24.
Publication Year :
2022

Abstract

Retromer is a heteropentameric complex that plays a specialized role in endosomal protein sorting and trafficking. Here, we report a reduction in the retromer proteins-vacuolar protein sorting 35 (VPS35), VPS26A, and VPS29-in patients with amyotrophic lateral sclerosis (ALS) and in the ALS model provided by transgenic (Tg) mice expressing the mutant superoxide dismutase-1 G93A. These changes are accompanied by a reduction of levels of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluA1, a proxy of retromer function, in spinal cords from Tg SOD1 <superscript>G93A</superscript> mice. Correction of the retromer deficit by a viral vector expressing VPS35 exacerbates the paralytic phenotype in Tg SOD1 <superscript>G93A</superscript> mice. Conversely, lowering Vps35 levels in Tg SOD1 <superscript>G93A</superscript> mice ameliorates the disease phenotype. In light of these findings, we propose that mild alterations in retromer inversely modulate neurodegeneration propensity in ALS.

Details

Language :
English
ISSN :
1091-6490
Volume :
119
Issue :
26
Database :
MEDLINE
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
35749364
Full Text :
https://doi.org/10.1073/pnas.2118755119